MiNK Therapeutics (INKT) Stock Chart & Stock Price History $7.70 +0.49 (+6.80%) Closing price 05/21/2025 03:55 PM EasternExtended Trading$7.88 +0.18 (+2.27%) As of 05/21/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Stock Price Performance The MiNK Therapeutics (INKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 23.00%, with a year-to-date return of 10.49%. In the past month, the stock has increased 2.26%, reflecting recent market activity. As of the latest close, MiNK Therapeutics traded at $7.70 with a market cap of $30.69 million and volume of 2,369 shares. Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.12%1 Month Performance+2.26%3 Month Performance-24.39%Year-To-Date Performance+10.49%1 Year Performance-23.00% INKT Stock Chart for Thursday, May, 22, 2025 INKT Chart by TradingView MiNK Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$7.46$7.70+3.22%$7.72$7.352,369 shs$30.69 million05/20/2025$7.60$7.46-1.84%$7.51$7.165,024 shs$29.74 million05/19/2025$7.54$7.60+0.80%$8.04$7.026,307 shs$30.14 million05/16/2025$7.45$7.54+1.21%$7.54$7.182,284 shs$29.90 million05/15/2025$7.50$7.45-0.67%$8.02$7.1813,871 shs$29.55 million05/14/2025$7.29$7.50+2.88%$7.98$6.9314,357 shs$29.75 million05/13/2025$7.60$7.29-4.08%$7.32$6.853,392 shs$28.91 million05/12/2025$7.03$7.60+8.11%$7.76$6.3411,068 shs$30.14 million05/09/2025$7.01$7.03+0.29%$7.33$6.664,463 shs$27.88 million05/08/2025$6.95$7.01+0.81%$7.40$6.665,830 shs$27.80 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$7.63$6.95-8.80%$7.38$7.382,379 shs$27.58 million05/06/2025$7.57$7.63+0.79%$7.68$7.384,117 shs$30.24 million05/05/2025$7.70$7.57-1.74%$7.95$7.244,262 shs$30.00 million05/02/2025$7.72$7.70-0.27%$7.97$7.201,683 shs$30.53 million05/01/2025$7.58$7.72+1.91%$7.40$7.40865 shs$30.62 million04/30/2025$7.86$7.58-3.63%$7.80$7.451,649 shs$30.04 million04/29/2025$7.49$7.86+5.01%$7.86$7.202,415 shs$31.17 million04/28/2025$7.70$7.49-2.79%$8.01$7.501,992 shs$29.69 million04/25/2025$7.47$7.70+3.08%$7.70$7.271,177 shs$30.54 million04/24/2025$7.65$7.47-2.35%$7.50$7.501,266 shs$29.63 million04/23/2025$7.53$7.65+1.59%$7.61$7.611,216 shs$30.34 million04/22/2025$7.26$7.53+3.72%$7.68$7.415,542 shs$29.86 million04/21/2025$7.63$7.26-4.85%$7.45$7.252,503 shs$28.79 million Related Companies Theratechnologies Stock Chart Black Diamond Therapeutics Stock Chart InflaRx Stock Chart Janone Stock Chart Vigil Neuroscience Stock Chart Vaxart Stock Chart Contineum Therapeutics Stock Chart Neumora Therapeutics Stock Chart Instil Bio Stock Chart Lexeo Therapeutics Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
